BenevolentAI
Applies artificial intelligence to accelerate drug discovery and development.
BAI | AS
Overview
Corporate Details
- ISIN(s):
- LU2355630455
- LEI:
- 2221003P54KEDC3P4Z33
- Country:
- United Kingdom
- Address:
- 4-8 Maple Street, W1T 5HD London
- Website:
- https://www.benevolent.com/
Description
BenevolentAI is a clinical-stage company that specializes in applying artificial intelligence (AI) and machine learning to drug discovery and development. The company utilizes its proprietary technology platform, which is built upon a comprehensive knowledge graph, to analyze vast amounts of complex biomedical information. This platform is designed to generate novel biological insights, identify new therapeutic targets, and accelerate the research and development process for new medicines. By integrating advanced AI with scientific expertise, BenevolentAI aims to decipher complex disease biology and improve the efficiency and success rate of bringing new treatments to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-27 17:24 |
PDMR Share Dealing Notification - JO (RSU settlement)
|
English | 52.3 KB | ||
| 2023-10-27 17:19 |
PDMR Share Dealing Notification - FN (RSU settlement)
|
English | 51.6 KB | ||
| 2023-10-11 13:14 |
PDMR Share Dealing Notification - IG (Cancellation and re-grant of 2022 RSUs) B…
|
English | 53.4 KB | ||
| 2023-10-11 13:06 |
PDMR Share Dealing Notification - IG (Grant of 2023 RSUs and PSUs)
|
English | 60.8 KB | ||
| 2023-10-11 12:59 |
PDMR Share Dealing Notification - CI (Grant of RSUs)
|
English | 51.4 KB | ||
| 2023-09-21 07:01 |
BAI HY23 Results_FINAL_21.09.23
|
English | 492.3 KB | ||
| 2023-09-21 07:00 |
BenevolentAI_Directorate Change_FINAL 21.09.2023
|
English | 129.8 KB | ||
| 2023-09-20 07:00 |
Merck Collaboration FINAL 20.09.23
|
English | 65.7 KB | ||
| 2023-09-11 07:00 |
BenevolentAI_CFO Appointment_FINAL_11.09.2023 (4)
|
English | 99.8 KB | ||
| 2023-08-31 07:00 |
BenevolentAI doses first participants in clinical trial of BEN-8744_FINAL_31.08…
|
English | 117.4 KB | ||
| 2023-06-21 07:00 |
BenevolentAI Press Release - NED Retirement
|
English | 62.9 KB | ||
| 2023-05-25 07:00 |
BenevolentAI unveils strategic plan to position the Company for a new era in AI…
|
English | 102.4 KB | ||
| 2023-04-05 07:00 |
BEN-2293 Phase IIa press release FINAL 05.04.2023[7]
|
English | 102.1 KB | ||
| 2023-03-24 07:00 |
2023 AGM Notice press release FINAL
|
English | 105.0 KB | ||
| 2023-03-22 07:00 |
MD NED PR FINAL 22 March
|
English | 39.1 KB |
Automate Your Workflow. Get a real-time feed of all BenevolentAI filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BenevolentAI
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BenevolentAI via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
